lidocaine has been researched along with Infections, Respiratory in 14 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lozenges containing lidocaine and cetylpyridinium chloride (CPC) are commonly used for the treatment of sore throat." | 9.27 | Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract in ( Donath, F; Furcha, R; Garreffa, S; Mallefet, P, 2018) |
| "The hexylresorcinol lozenge demonstrated superiority over placebo for primary and secondary efficacy variables including those related to throat soreness, sore throat relief and difficulty swallowing; the AMC/DCBA + lidocaine lozenge was also superior to placebo for secondary endpoints at various time points but did not reach significance for the primary efficacy variable." | 9.16 | Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection. ( Field, E; McNally, D; Shephard, A, 2012) |
| "Lozenges containing lidocaine and cetylpyridinium chloride (CPC) are commonly used for the treatment of sore throat." | 5.27 | Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract in ( Donath, F; Furcha, R; Garreffa, S; Mallefet, P, 2018) |
| "The hexylresorcinol lozenge demonstrated superiority over placebo for primary and secondary efficacy variables including those related to throat soreness, sore throat relief and difficulty swallowing; the AMC/DCBA + lidocaine lozenge was also superior to placebo for secondary endpoints at various time points but did not reach significance for the primary efficacy variable." | 5.16 | Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection. ( Field, E; McNally, D; Shephard, A, 2012) |
| "To evaluate the action of 2% lidocaine on the culture results of bronchial fluid in patients suspected of having lower respiratory tract infections." | 3.85 | Effect of Lidocaine 2% on Bacterial Culture of Bronchial Fluid. ( Ayatollahi, J; Fallah, T; Meybodi, FAA; Mokarianpour, T; Mongabadi, FD; Samet, M; Shahcheraghi, SH; Yazdi, MHA, 2017) |
| "Ertapenem is a new, structurally unique, parenteral beta-lactam antimicrobial agent that can be administered once daily." | 2.70 | Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone. ( Friedland, I; Jiang, Q; Legua, P; Lema, J; Moll, J; Woods, G, 2002) |
| "cephacetrile were respectively 14." | 2.64 | Cephacetrile, a new cephalosporin: in vitro, pharmacological and clinical evaluation. ( Bals, MG; Toma, E, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samet, M | 1 |
| Meybodi, FAA | 1 |
| Mokarianpour, T | 1 |
| Fallah, T | 1 |
| Mongabadi, FD | 1 |
| Ayatollahi, J | 1 |
| Shahcheraghi, SH | 1 |
| Yazdi, MHA | 1 |
| Donath, F | 1 |
| Mallefet, P | 1 |
| Garreffa, S | 1 |
| Furcha, R | 1 |
| Dadure, C | 1 |
| Sabourdin, N | 1 |
| Veyckemans, F | 1 |
| Babre, F | 1 |
| Bourdaud, N | 1 |
| Dahmani, S | 1 |
| Queiroz, M | 1 |
| Devys, JM | 1 |
| Dubois, MC | 1 |
| Kern, D | 1 |
| Laffargue, A | 1 |
| Laffon, M | 1 |
| Lejus-Bourdeau, C | 1 |
| Nouette-Gaulain, K | 1 |
| Orliaguet, G | 1 |
| Gayat, E | 1 |
| Velly, L | 1 |
| Salvi, N | 1 |
| Sola, C | 1 |
| Noitasaeng, P | 1 |
| Vichitvejpaisal, P | 1 |
| Kaosombatwattana, U | 1 |
| Tassanee, J | 1 |
| Suwannee, S | 1 |
| Schebesta, K | 1 |
| Güloglu, E | 1 |
| Chiari, A | 1 |
| Mayer, N | 1 |
| Kimberger, O | 1 |
| McNally, D | 1 |
| Shephard, A | 1 |
| Field, E | 1 |
| Chandan, SS | 1 |
| Faoagali, J | 1 |
| Wainwright, CE | 1 |
| Joshi, JH | 1 |
| Wang, KP | 1 |
| de Jongh, CA | 1 |
| Newman, KA | 1 |
| Wiernik, PH | 1 |
| Schimpff, SC | 1 |
| Hall, AP | 1 |
| Fox, AJ | 1 |
| Raphael, JH | 1 |
| Nandwani, N | 1 |
| Smith, G | 1 |
| Peleg, R | 1 |
| Binyamin, L | 1 |
| Legua, P | 1 |
| Lema, J | 1 |
| Moll, J | 1 |
| Jiang, Q | 1 |
| Woods, G | 1 |
| Friedland, I | 1 |
| Bals, MG | 1 |
| Toma, E | 1 |
| Phillips, I | 1 |
| Wanner, A | 1 |
| Amikam, B | 1 |
| Robinson, MJ | 1 |
| Anandam, EJ | 1 |
| Sackner, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Parallel Group, Single-dose Study of the Efficacy of Lidocaine 8 mg + Cetylpyridinium Chloride (CPC) 2 mg Fixed Combination Lozenges on Sore Throat Pain Intensity Compared to Lozenges Containing Lidocaine 1 mg and CPC 2 mg in S[NCT01265446] | Phase 3 | 250 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
100 milimeter (mm) visual acuity score (left=no pain=0mm, right=worst possible pain=100mm) (NCT01265446)
Timeframe: Baseline and 2 hours post-dose
| Intervention | mm (Mean) |
|---|---|
| Lidocaine 8mg +CPC 2mg | -27.4 |
| Lidocaine 1mg + CPC 2mg | -26.9 |
100 milimeter (mm) visual acuity score (left=no pain=0mm, right=worst possible pain=100mm). It measures the highest pain level felt by the patient. (NCT01265446)
Timeframe: Baseline and 240 mn post-dose
| Intervention | mm (Mean) |
|---|---|
| Lidocaine 8mg +CPC 2mg | -25.5 |
| Lidocaine 1mg + CPC 2mg | -29.1 |
7 trials available for lidocaine and Infections, Respiratory
| Article | Year |
|---|---|
Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract in
Topics: Administration, Oral; Adult; Anesthetics, Local; Anti-Infective Agents, Local; Cetylpyridinium; Doub | 2018 |
Comparison of Spraying and Nebulized Lidocaine in Patients Undergoing Esophago-Gastro-Duodenoscopy: A Randomized Trial.
Topics: Adult; Aged; Anesthetics, Local; Endoscopy, Digestive System; Female; Humans; Lidocaine; Male; Middl | 2016 |
Topical lidocaine reduces the risk of perioperative airway complications in children with upper respiratory tract infections.
Topics: Administration, Topical; Aging; Anesthesia; Anesthesia Recovery Period; Anesthetics, Local; Child; C | 2010 |
Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Anti-Infective Agents, Local; Benzyl Alcohols; Cresols; | 2012 |
Upper airway reactivity and upper respiratory tract infection: effect of nebulized lidocaine.
Topics: Adult; Airway Resistance; Ammonia; Analysis of Variance; Anesthetics, Local; Double-Blind Method; Fo | 1999 |
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
Topics: Aged; Anesthetics, Local; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-B | 2002 |
Cephacetrile, a new cephalosporin: in vitro, pharmacological and clinical evaluation.
Topics: Bacteria; Cephacetrile; Cephalosporins; Clinical Trials as Topic; Drug Tolerance; Enterobacteriaceae | 1975 |
7 other studies available for lidocaine and Infections, Respiratory
| Article | Year |
|---|---|
Effect of Lidocaine 2% on Bacterial Culture of Bronchial Fluid.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross | 2017 |
Management of the child's airway under anaesthesia: The French guidelines.
Topics: Administration, Topical; Airway Extubation; Airway Management; Algorithms; Child; Child, Preschool; | 2019 |
Sensitivity of respiratory bacteria to lignocaine.
Topics: Anesthetics, Local; Animals; Bacteria; Candida albicans; Dose-Response Relationship, Drug; Haemophil | 2005 |
A comparative evaluation of two fiberoptic bronchoscopy catheters: the plugged telescoping catheter versus the single sheathed nonplugged catheter.
Topics: Aerosols; Bronchoscopes; Catheterization; Fiber Optic Technology; Humans; Lidocaine; Neoplasms; Pros | 1982 |
Practice tips. Treating persistent cough. Try a nebulized mixture of lidocaine and bupivacaine.
Topics: Administration, Inhalation; Anesthetics, Local; Bupivacaine; Chronic Disease; Cough; Humans; Lidocai | 2002 |
Postoperative respiratory-tract infection with Pseudomonas aeruginosa due to contaminated lignocaine jelly.
Topics: Adult; Aged; Anesthesia, Endotracheal; Humans; Lidocaine; Male; Middle Aged; Postoperative Complicat | 1966 |
Comparison between the bacteriologic flora of different segments of the airways. Examination by bedside bronchofiberscopy.
Topics: Aged; Bronchi; Bronchoscopy; Fiber Optic Technology; Humans; Lidocaine; Lung Diseases; Middle Aged; | 1973 |